Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
“At a critical point in our company’s history, we decided to take a very close look at our business processes and examine ways in which we could properly position the company for significant growth in the coming years.”
Vice President of Finance, Curse, Inc
“We needed the robust functionality of a hosted environment to manage our global business. So we decided to make the move to Oracle Fusion Financials and found it is a good fit to our business needs, right out of the box.”
Controller, Pinterest, Inc.
“We’re pleased to partner with Infovity, given their deep industry experience with social media companies and successful track record of implementing Oracle E-Business Suite 12.”